Neonatal ichthyosis–sclerosing cholangitis syndrome
Neonatal ichthyosis–sclerosing cholangitis syndrome (NISCH syndrome) is a rare autosomal recessive genetic disorder that affects the skin and liver. The syndrome is characterized by ichthyosis, which is a condition that causes dry, scaly skin, and sclerosing cholangitis, a disease that leads to inflammation and scarring of the bile ducts in the liver.
Etymology[edit | edit source]
The term "Neonatal ichthyosis–sclerosing cholangitis syndrome" is derived from the main symptoms of the condition. "Neonatal" refers to the period immediately after birth, "ichthyosis" is a term for a group of skin disorders that cause dry, scaly skin, and "sclerosing cholangitis" is a condition that causes inflammation and scarring of the bile ducts in the liver.
Symptoms[edit | edit source]
The main symptoms of NISCH syndrome are neonatal ichthyosis and sclerosing cholangitis. Other symptoms may include growth retardation, hepatomegaly (enlarged liver), and splenomegaly (enlarged spleen). Some patients may also develop cirrhosis of the liver.
Causes[edit | edit source]
NISCH syndrome is caused by mutations in the CLDN1 gene. This gene provides instructions for making a protein that is essential for the proper function of tight junctions, which are connections between cells that prevent the leakage of fluid.
Diagnosis[edit | edit source]
Diagnosis of NISCH syndrome is based on the presence of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and a variety of specialized tests. These tests may include skin biopsy, liver biopsy, and genetic testing.
Treatment[edit | edit source]
There is currently no cure for NISCH syndrome. Treatment is symptomatic and supportive, and may include measures to manage ichthyosis, such as the use of moisturizers and keratolytic agents, and treatment of liver disease.
See also[edit | edit source]
Neonatal ichthyosis–sclerosing cholangitis syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD